Published : 30 July, 2024
Dr. Ullas Batra, Co-Director of Medical Oncology and Chief of Thoracic Medical Oncology at Rajiv Gandhi Cancer Institute, commends the Union Budget 2024 for its support of cancer care. He particularly applauds the customs duty exemptions on cancer medicines, which will make essential drugs more affordable for patients. Dr. Batra sees this move as a strategic effort to boost domestic production and improve healthcare accessibility. This initiative is a significant step towards advancing healthcare infrastructure and reducing treatment costs. By lowering drug prices, the customs duty exemptions are expected to benefit cancer patients, particularly those who otherwise could not afford such crucial medications.
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
DONATE